Diabetes affects millions worldwide, often triggering complications such as insulin resistance and fatty liver disease. To ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

This simple, cost-effective tool has the potential to revolutionize type 2 diabetes care, helping millions of people ...

Biomedical engineer Joshua Doloff uses federal funding to pioneer immunotherapies that could free diabetes patients from ...

Anyone who has tried to lose weight by cutting calories knows the frustration—after initial success, weight loss slows down ...

Gemiglo is the first domestic diabetes medication brand to surpass 1 trillion won in sales. Sales of the Gemiglo product line ...

Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

The Yukon and federal governments have agreed on Phase 1 of a pharmacare deal to provide universal access to contraceptive ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...